Skip to main content

Analysts Offer Insights on Healthcare Companies: Scholar Rock Holding (SRRK), Zimmer Biomet Holdings (ZBH) and Hinge Health, Inc. Class A (HNGE)

Tipranks - Tipranks - Tue Nov 18, 2025

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Scholar Rock Holding (SRRK – Research Report), Zimmer Biomet Holdings (ZBH – Research Report) and Hinge Health, Inc. Class A (HNGE – Research Report).

Meet Your ETF AI Analyst

Scholar Rock Holding (SRRK)

In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on Scholar Rock Holding, with a price target of $44.00. The company’s shares closed last Friday at $37.41.

According to TipRanks.com, Devarakonda is a 4-star analyst with an average return of 11.8% and a 50.2% success rate. Devarakonda covers the Healthcare sector, focusing on stocks such as Protagonist Therapeutics, Madrigal Pharmaceuticals, and MBX Biosciences, Inc. ;'>

Scholar Rock Holding has an analyst consensus of Strong Buy, with a price target consensus of $47.33, representing a 35.3% upside. In a report issued on November 14, BMO Capital also maintained a Buy rating on the stock with a $50.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Zimmer Biomet Holdings (ZBH)

Truist Financial analyst Richard Newitter reiterated a Hold rating on Zimmer Biomet Holdings today. The company’s shares closed last Friday at $89.91.

According to TipRanks.com, Newitter is a 5-star analyst with an average return of 13.4% and a 55.8% success rate. Newitter covers the Healthcare sector, focusing on stocks such as Treace Medical Concepts, Inspire Medical Systems, and Irhythm Technologies. ;'>

Currently, the analyst consensus on Zimmer Biomet Holdings is a Hold with an average price target of $104.65, a 15.1% upside from current levels. In a report issued on November 5, Wells Fargo also initiated coverage with a Hold rating on the stock with a $93.00 price target.

Hinge Health, Inc. Class A (HNGE)

Truist Financial analyst Jailendra Singh maintained a Buy rating on Hinge Health, Inc. Class A today. The company’s shares closed last Friday at $40.96.

According to TipRanks.com, Singh has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -14.2% and a 33.1% success rate. Singh covers the Healthcare sector, focusing on stocks such as Fortrea Holdings Inc., Privia Health Group, and Hims & Hers Health. ;'>

Hinge Health, Inc. Class A has an analyst consensus of Strong Buy, with a price target consensus of $64.68, representing a 57.8% upside. In a report issued on November 3, Barclays also maintained a Buy rating on the stock with a price target.

Read More on SRRK:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).